Merakris Therapeutics, LLC Announces the Commercial Launch of Dermacyte® Matrix and CMS Assignment of an HCPCS Code for Use as a Skin Graft Substitute New HCPCS Code Enables Facility Reimbursement to Physician Offices Performing Skin Graft Substitute Procedures, Benefiting Wound Patients RESEARCH TRIANGLE PARK, N.C.--( BUSINESS WIRE )-- Merakris Therapeutics, LLC., a leader in innovative approaches for cutaneous wound healing, announces that the Center
July 9, 2020
· 2 min read